Compare Infosys Limited (INFY) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Infosys Limited vs Intuitive Surgical, Inc. — how do they compare? Infosys Limited trades at $10.73 (market cap $41.74B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 3.5× Infosys Limited's market cap, and Infosys Limited pays a 4.89% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Infosys Limited for 27 Days and Intuitive Surgical, Inc. for 84 Days on average.
| INFY | ISRG | |
|---|---|---|
Market Cap | $41.74B | $146.76B |
Volume | 31,354,285 | 2,529,814 |
Sector | Technology | Health |
52-Week High | $20.22 | $592.85 |
52-Week Low | $10.49 | $332.02 |
Typical Hold Time | 27 Days | 84 Days |
Enterprise Value | $39.48B | $141.54B |
Dividend Yield | 4.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INFY trades at $10.73, up 1.71% today, with a bearish technical signal from moving averages. The company reported revenue of $19.28B in 2025, with a net income margin of 16.37% and a P/E ratio of 13.21. Recent earnings show mixed results, beating estimates in Q4 2025 and Q1 2026 but missing in Q2 2026. News highlights strategic AI collaborations, such as with Columbia University and ABN Amro, aiming to drive innovation.
The outlook is cautious due to bearish technicals and a slight decline in 2026 cash flow projections. Analyst consensus is a 'Hold' with a $11.48 price target, suggesting limited upside. Risks include competitive pressures in IT services and macroeconomic headwinds affecting Western IT spending. The stock's current valuation appears reasonable, but growth catalysts from AI initiatives need to materialize to support a bullish case.
Intuitive Surgical (ISRG) trades at $423.96, up 2.28% with strong bullish momentum. The stock shows robust fundamentals with 2025 revenue reaching $10.06B and net income of $2.86B, maintaining 28.45% net margins. Recent quarters consistently beat EPS estimates, while technical indicators signal bullish moving averages. Analyst consensus remains strongly positive with 70% buy ratings and $480.78 price target, representing 13% upside potential.
ISRG's leadership in robotic surgery and expanding international presence in India and Japan provide growth catalysts, though China weakness and competitive pressures present risks. The stock's premium valuation (P/E 47.64) reflects high growth expectations, requiring continued execution. Current levels near resistance at $427 may test near-term momentum ahead of Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
